MYCOF News and Press, New Age Brands From 03/29/22

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) , a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, has continually taken steps toward fulfilling its mission to become a trusted source of safe and effective medication-ba...

Research has found that a virtual connection to a psychiatrist may help people living in rural communities and grappling with bipolar disorder and post-traumatic stress disorder  acquire effective care. The randomized study, which was carried out before the coronavirus pandemic, exami...

Prior studies have found that psychedelic substances can alter states of consciousness . However, until now it was unknown which receptors played a role in this change. New research conducted by a group of scientists from various institutions has demonstrated how a drug-induced change in an...

Last week, the joint Public Health Committee in Connecticut passed a measure that would allow the state to offer eligible patients access to psychedelic-assisted treatment . The bill, HB 5396, was approved on a noncontroversial basis and will be advancing to the floor for consideration. T...

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) , a biotechnology company aiming to transform the treatment of mental health and addiction disorders, has received conditional approval from the Institutional Review Board ("IRB") for its planned multisite phase 2b smoking cessa...

DENVER, March 24, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today announced ...

While almost every individual will experience a traumatic event at least once in their lifetime, not everybody will develop post-traumatic stress disorder (“PTSD”). Research has found that unlike the general population, some groups do undergo experiences that make them more s...

We recently saw Russia invade Ukraine, which prompted millions of Ukrainians to flee their homes as the war intensified. Disturbing videos and photos of the damage done to buildings and people in cities such as Kharkov and Kyiv can be accessed online, even by those thousands of miles away....

Various companies and experts are hailing psychedelics such as MDMA, LSD and psilocybin, as well as mind-altering substances such as ketamine, as the next revolutionary treatment for a number of mental health conditions. The surge in the popularity of psychedelic substances started alm...

Mydecine participated in this year’s Annual Roth Conference, the Oppenheimer & Co. Annual Healthcare Conference, and will be at the upcoming Maxim Group’s Virtual Growth Conference These conferences represent an opportunity for the company to share its R&D pipeline...